Follow
Gareth Veal
Gareth Veal
Professor of Cancer Pharmacology, Newcastle University
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Human renal function maturation: a quantitative description using weight and postmenstrual age
MM Rhodin, BJ Anderson, AM Peters, MG Coulthard, B Wilkins, M Cole, ...
Pediatric nephrology 24 (1), 67-76, 2009
4352009
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised …
B Seddon, SJ Strauss, J Whelan, M Leahy, PJ Woll, F Cowie, ...
The lancet oncology 18 (10), 1397-1410, 2017
2992017
Review of therapeutic drug monitoring of anticancer drugs part two–targeted therapies
N Widmer, C Bardin, E Chatelut, A Paci, J Beijnen, D Levêque, G Veal, ...
European journal of cancer 50 (12), 2020-2036, 2014
2932014
Review of therapeutic drug monitoring of anticancer drugs part 1–cytotoxics
A Paci, G Veal, C Bardin, D Levêque, N Widmer, J Beijnen, A Astier, ...
European journal of cancer 50 (12), 2010-2019, 2014
2302014
Sodium thiosulfate for protection from cisplatin-induced hearing loss
PR Brock, R Maibach, M Childs, K Rajput, D Roebuck, MJ Sullivan, ...
New England Journal of Medicine 378 (25), 2376-2385, 2018
1742018
Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells
JL Armstrong, R Flockhart, GJ Veal, PE Lovat, CPF Redfern
Journal of Biological Chemistry 285 (9), 6091-6100, 2010
1682010
Metabolism of zidovudine
GJ Veal, DJ Back
General pharmacology: The vascular system 26 (7), 1469-1475, 1995
1291995
The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
MG Barry, SH Khoo, GJ Veal, PG Hoggard, SE Gibbons, EG Wilkins, ...
AIDS (London, England) 10 (12), 1361-1367, 1996
1161996
Therapeutic drug monitoring in cancer–are we missing a trick?
C Bardin, G Veal, A Paci, E Chatelut, A Astier, D Levêque, N Widmer, ...
European journal of cancer 50 (12), 2005-2009, 2014
1132014
Clinical pharmacology in the adolescent oncology patient
GJ Veal, CM Hartford, CF Stewart
Journal of clinical oncology 28 (32), 4790, 2010
1042010
Lamivudine (3TC) phosphorylation and drug interactions in vitro
S Kewn, GJ Veal, PG Hoggard, MG Barry, DJ Back
Biochemical pharmacology 54 (5), 589-595, 1997
1011997
Oxazaphosphorines: new therapeutic strategies for an old class of drugs
B Giraud, G Hebert, A Deroussent, GJ Veal, G Vassal, A Paci
Expert opinion on drug metabolism & toxicology 6 (8), 919-938, 2010
922010
A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin
GJ Veal, MJ Griffin, E Price, A Parry, GS Dick, MA Little, SM Yule, ...
British journal of cancer 84 (8), 1029-1035, 2001
902001
Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
M Barry, M Wild, G Veal, D Back, A Breckenridge, R Fox, N Beeching, ...
AIDS (London, England) 8 (8), F1-5, 1994
781994
The oncogenic transcription factor RUNX1/ETO corrupts cell cycle regulation to drive leukemic transformation
N Martinez-Soria, L McKenzie, J Draper, A Ptasinska, H Issa, S Potluri, ...
Cancer Cell 34 (4), 626-642. e8, 2018
712018
13-cis retinoic acid and isomerisation in paediatric oncology—is changing shape the key to success?
JL Armstrong, CPF Redfern, GJ Veal
Biochemical pharmacology 69 (9), 1299-1306, 2005
712005
Clinical and cellular pharmacology in relation to solid tumours of childhood
EJ Estlin, GJ Veal
Cancer treatment reviews 29 (4), 253-273, 2003
692003
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study
GJ Veal, M Cole, J Errington, A Parry, J Hale, ADJ Pearson, K Howe, ...
Clinical cancer research 11 (16), 5893-5899, 2005
662005
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy
GJ Veal, C Dias, L Price, A Parry, J Errington, J Hale, ADJ Pearson, ...
Clinical cancer research 7 (8), 2205-2212, 2001
602001
Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours
JL Armstrong, GJ Veal, CPF Redfern, PE Lovat
Apoptosis 12 (3), 613-622, 2007
592007
The system can't perform the operation now. Try again later.
Articles 1–20